S. M. Kloosterboer

发表

B. Koch, L. Al-Hassany, S. M. Kloosterboer, 2019, Patient preference and adherence.

M. van Dijk, M. Hillegers, T. van Gelder, 2020, Therapeutic drug monitoring.

M. Gerlach, M. Hillegers, K. Egberts, 2020, Expert opinion on drug safety.

S. M. Kloosterboer, A. V. van Zanten, 2015, American journal of respiratory and critical care medicine.

T. van Gelder, B. D. de Winter, G. Dieleman, 2018, Therapeutic drug monitoring.

B. Koch, L. Al-Hassany, S. M. Kloosterboer, 2019 .

M. Hillegers, T. van Gelder, J. van der Ende, 2020, European Child & Adolescent Psychiatry.

H. Bos, M. Hillegers, B. D. de Winter, 2022, European Child & Adolescent Psychiatry.

K. Nasserinejad, M. Hillegers, R. V. van Schaik, 2020, British journal of clinical pharmacology.

M. V. van Driel, T. Verheij, S. M. Kloosterboer, 2015, Australian family physician.

D. Hesselink, B. D. de Winter, S. M. Kloosterboer, 2022, Therapeutic drug monitoring.

H. Bos, M. Hillegers, B. D. de Winter, 2022, European Child & Adolescent Psychiatry.

B. D. de Winter, S. M. Kloosterboer, B. Dierckx, 2023, Therapeutic drug monitoring.

B. Koch, L. Al-Hassany, S. M. Kloosterboer, 2019 .